Cuq Juliette, Lapoirie Marion, Plotton Ingrid, Fraison Eloise, Neuville Paul, Oriol Séverine
Hospices civils de Lyon, université Claude-Bernard, Lyon, France.
Service de médecine de la reproduction, hôpital Lyon Est, Lyon, France.
Gynecol Obstet Fertil Senol. 2024 Dec;52(12):710-719. doi: 10.1016/j.gofs.2024.06.004. Epub 2024 Aug 2.
Transmasculine individuals have a poor access to health care, mostly regarding the sexual and reproductive health. Despite a lack of official guidelines, they need a gynecological follow-up, the aim of this review was to describe it. The present study involved an exhaustive search of MEDLINE, 68 articles were included to analyze the impact of hormonal therapy, prevention, and care regarding sexual and reproductive health of transmasculine individuals. Despite a lack of solid data, the global literature agrees that transmasculine individuals require sexual and reproductive health care. Care must be adapted to each pathway and may be impacted by gender-affirming care. The cancer risk does not seem to be increased in this population, particularly in relation to hormonal therapy. Prevention programs do not differ from those offered to cis women in the absence of gender-affirming surgeries. Transmasculine individuals require follow-up and care adapted to their needs and their pathways. Healthcare professionals must be trained to provide such care.
跨性别男性在获得医疗保健方面存在困难，主要涉及性健康和生殖健康。尽管缺乏官方指南，但他们需要妇科随访，本综述的目的就是对此进行描述。本研究对MEDLINE进行了全面检索，纳入了68篇文章，以分析激素治疗、预防以及跨性别男性性健康和生殖健康护理的影响。尽管缺乏确凿数据，但全球文献一致认为跨性别男性需要性健康和生殖健康护理。护理必须根据每个人的情况进行调整，并且可能会受到性别肯定护理的影响。该人群的癌症风险似乎并未增加，尤其是与激素治疗相关的风险。在没有性别肯定手术的情况下，预防计划与为顺性别女性提供的计划并无不同。跨性别男性需要根据其需求和情况进行随访和护理。医疗保健专业人员必须接受培训以提供此类护理。
